President, Management

Velocity Bioworks is a U.S.

-based biopharma CDMO headquartered in San Antonio, Texas supporting funded programs as they move from development into manufacturing for clinical trials. We collaborate with sponsors who are past exploration and are ready to apply discipline, structure, and technical rigor to development, analytics, and manufacturing.

Velocity is built to accelerate speed to clinic through aligned execution. Our work focuses on translating defined program goals into scalable manufacturing processes and robust analytical strategies. These activities are designed to support near‑term clinical timelines while meeting quality requirements. We operate where quality and execution directly influence clinical and business progress.

The President is the senior executive leader with full responsibility for Velocity Bioworks’ Large Molecule (Biologics) Contract Development and Manufacturing Organization (CDMO) facility in San Antonio, Texas encompassing both mammalian and microbial expression platforms. Reporting directly to the CEO of Tivic Health, this role holds full P&L accountability and is responsible for the strategic, operational, financial, and regulatory performance of the biologics CDMO.

The President will lead end‑to‑end biologics development and manufacturing operations, including business development, process development, clinical and commercial manufacturing, quality systems, and supply chain, while scaling capabilities to meet growing customer demand. This role is critical to positioning Velocity Bioworks as a trusted, high‑quality biologics CDMO partner.

• Develop and execute the strategic plan for the Large Molecule CDMO, integrating mammalian (e.g., CHO‑based) and microbial (e.g.,
  
  E. coli, yeast) platforms
• Drive growth through expansion of development and manufacturing business across both expression systems
• Partner with the CEO and Tivic Health leadership on capital investments, platform expansion, and technology roadmaps aligned with commercial progress
• Represent the CDMO business with customers, partners, regulators, and external stakeholders
• Provide executive oversight for biologics operations, including:
• Mammalian and microbial cell line development
• Upstream and downstream process development and manufacturing
• Drug substance manufacturing for clinical and commercial programs
• Formulation, tech transfer, and lifecycle management
• Ensure seamless execution of multi‑platform development and manufacturing programs
• Establish standardized yet flexible operating models across mammalian and microbial processes
• Drive operational excellence, safety, and reliability across all manufacturing suites

• Ensure full compliance with global cGMP and regulatory requirements (FDA, EMA, ICH, ISO) across both mammalian and microbial operations
• Maintain inspection readiness and serve as executive sponsor for regulatory inspections and customer audits
• Oversee quality systems, validation, data integrity, contamination control, and risk management programs
• Foster a strong quality culture appropriate for multi-modal biologics manufacturing
• Own full P&L responsibility for the Velocity Bioworks business, currently the San Antonio CDMO site
• Develop and manage budgets, forecasts, and long‑range financial plans
• Drive profitability through capacity utilization, cost discipline, and platform‑specific pricing strategies
• Monitor ROI on capital investments across mammalian and microbial platforms
• Act as executive sponsor for key CDMO customers utilizing mammalian and/or microbial technologies
• Ensure exceptional customer experience across development, manufacturing, and tech transfer activities
• Support business development efforts with technical, operational, and executive‑level engagement
• Build and lead a high‑performing leadership team with deep expertise in both mammalian and microbial biologics
• Attract, develop, and retain specialized talent across upstream, downstream, analytics, and quality functions
• Foster a culture of accountability, collaboration, safety, and continuous improvement
• Ensure succession planning and…